TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porterโs Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Augmented Bone Graft Market, By Imaging Modality
6.1 Introduction
6.2 Allografts
6.2.1 Market Estimates & Forecast, 2016 โ 2023
6.3 Bone Grafts Substitutes
6.3.1 Market Estimates & Forecast, 2016 โ 2023
6.4 Cell-Based Matrices
6.4.1 Market Estimates & Forecast, 2016 โ 2023
Chapter 7. Global Augmented Bone Graft Market, By Applications
7.1 Introduction
7.2 Craniomaxillofacial
7.2.1 Market Estimates & Forecast, 2020 โ 2027
7.3 Dental
7.3.1 Market Estimates & Forecast, 2020 โ 2027
7.4 Foot & Ankle
7.4.1 Market Estimates & Forecast, 2020 โ 2027
7.5 Joint Reconstruction
7.5.1 Market Estimates & Forecast, 2020 โ 2027
7.6 Long Bone
7.6.1 Market Estimates & Forecast, 2020 โ 2027
7.7 Spinal Fusion
7.7.1 Market Estimates & Forecast, 2020 โ 2027
Chapter 8. Global Augmented Bone Graft Market, By End User
8.1 Introduction
8.2 Hospitals
8.2.1 Market Estimates & Forecast, 2020 โ 2027
8.3 Clinics
8.3.2 Market Estimates & Forecast, 2020 โ 2027
8.4 Ambulatory Surgical Centers
8.4.2 Market Estimates & Forecast, 2020 โ 2027
8.5 Others
8.5.2 Market Estimates & Forecast, 2020 โ 2027
Chapter .9 Global Augmented Bone Graft Market, By Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 U.S.
9.2.1.1 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 U.K
9.3.1.6 Rest Of Western Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Republic Of Korea
9.4.6 Rest Of Asia Pacific
9.5 The Middle East & Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.3 Oman
9.5.4 Kuwait
9.5.5 Qatar
9.5.6 Rest Of The Middle East & Africa
Chapter 10 Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
10.3.1 Key Developments
Chapter 11 Company Profiles
11.1 Wright Medical Group
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials
11.1.4 SWOT Analysis
11.2 Zimmer Holdings, Inc.
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 BioMimetic Therapeutics LLC
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Stryker Corporation
11.4.1 Company Overview
11.4.2 Product/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 NovaBone Products LLC
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial Overview
11.5.4 Key Developments
11.6 RTI Surgical, Inc.
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.7 Olympus Biotech Corporation.
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 NuVasive, Inc.
11.8.1 Company Overview
11.8.2 Product/Business Segment Overview
11.8.3 Financial Overview
11.8.4 Key Development
11.8.5 SWOT Analysis
11.9 Smith & Nephew Plc
11.9.1 Company Overview
11.9.2 Product Overview
11.9.3 Financial Overview
11.9.4 Key Developments
11.10 Others
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEOโs View Point
12.1.2 Unmet Needs Of The Market
12.2 Key Companies To Watch
12.3 Prediction Of Pharmaceutical Industry
Chapter 13 Appendix
LIST OF TABLES
Table 1 Augmented Bone Graft Industry Synopsis, 2020 โ 2027
Table 2 Augmented Bone Graft Market Estimates And Forecast, 2020 โ 2027, (USD Million)
Table 3 Augmented Bone Graft Market By Region, 2020 โ 2027, (USD Million)
Table 4 Augmented Bone Graft Market By Diagnosis, 2020 โ 2027, (USD Million)
Table 5 Augmented Bone Graft Market By Treatment, 2020 โ 2027, (USD Million)
Table 6 Augmented Bone Graft Market By End Users, 2020 โ 2027, (USD Million)
Table 7 North America Augmented Bone Graft Market By Diagnosis, 2020 โ 2027, (USD Million)
Table 8 North America Augmented Bone Graft Market By Treatment, 2020 โ 2027, (USD Million)
Table 9 North America Augmented Bone Graft Market By End Users, 2020 โ 2027, (USD Million)
Table 10 US Augmented Bone Graft Market By Diagnosis, 2020 โ 2027, (USD Million)
Table 11 US Augmented Bone Graft Market By Treatment, 2020 โ 2027, (USD Million)
Table 12 US Augmented Bone Graft Market By End Users, 2020 โ 2027, (USD Million)
Table 13 Canada Augmented Bone Graft Market By Diagnosis, 2020 โ 2027, (USD Million)
Table 14 Canada Augmented Bone Graft Market By Treatment, 2020 โ 2027, (USD Million)
Table 15 Canada Augmented Bone Graft Market By End Users, 2020 โ 2027, (USD Million)
Table 16 South America Augmented Bone Graft Market By Diagnosis, 2020 โ 2027, (USD Million)
Table 17 South America Augmented Bone Graft Market By Treatment, 2020 โ 2027, (USD Million)
Table 18 South America Augmented Bone Graft Market By End Users, 2020 โ 2027, (USD Million)
Table 19 Europe Augmented Bone Graft Market By Diagnosis, 2020 โ 2027, (USD Million)
Table 20 Europe Augmented Bone Graft Market By Treatment, 2020 โ 2027, (USD Million)
Table 21 Europe Augmented Bone Graft Market By End Users, 2020 โ 2027, (USD Million)
Table 22 Western Europe Augmented Bone Graft Market By Diagnosis, 2020 โ 2027, (USD Million)
Table 23 Western Europe Augmented Bone Graft Market By Treatment, 2020 โ 2027, (USD Million)
Table 24 Western Europe Augmented Bone Graft Market By End Users, 2020 โ 2027, (USD Million)
Table 25 Eastern Europe Augmented Bone Graft Market By Diagnosis, 2020 โ 2027, (USD Million)
Table 26 Eastern Europe Augmented Bone Graft Market By Treatment, 2020 โ 2027, (USD Million)
Table 27 Eastern Europe Augmented Bone Graft Market By End Users, 2020 โ 2027, (USD Million)
Table 28 Asia Pacific Augmented Bone Graft Market By Diagnosis, 2020 โ 2027, (USD Million)
Table 29 Asia Pacific Augmented Bone Graft Market By Treatment, 2020 โ 2027, (USD Million)
Table 30 Asia Pacific Augmented Bone Graft Market By End Users, 2020 โ 2027, (USD Million)
Table 31 Middle East & Africa Augmented Bone Graft Market By Diagnosis, 2020 โ 2027, (USD Million)
Table 32 Middle East & Africa Augmented Bone Graft Market By Treatment, 2020 โ 2027, (USD Million)
Table 33 Middle East & Africa Augmented Bone Graft Market By End Users, 2020 โ 2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Augmented Bone Graft Market
Figure 3 Segmentation Market Dynamics For Augmented Bone Graft Market
Figure 4 Global Augmented Bone Graft Market Share, By Diagnosis 2016
Figure 5 Global Augmented Bone Graft Market Share, By Treatment 2016
Figure 6 Global Augmented Bone Graft Market Share, By End Users, 2016
Figure 7 Global Augmented Bone Graft Market Share, By Region, 2016
Figure 8 North America Augmented Bone Graft Market Share, By Country, 2016
Figure 9 Europe Augmented Bone Graft Market Share, By Country, 2016
Figure 10 Asia Pacific Augmented Bone Graft Market Share, By Country, 2016
Figure 11 Middle East & Africa Augmented Bone Graft Market Share, By Country, 2016
Figure 12 Global Augmented Bone Graft Market: Company Share Analysis, 2016 (%)
Figure 13 Wright Medical Technology, Inc.: Key Financials
Figure 14 Wright Medical Technology, Inc.: Segmental Revenue
Figure 15 Wright Medical Technology, Inc.: Geographical Revenue
Figure 16 Zimmer Holdings, Inc.: Key Financials
Figure 17 Zimmer Holdings, Inc.: Segmental Revenue
Figure 18 Zimmer Holdings, Inc.: Geographical Revenue
Figure 19 BioMimetic Therapeutics LLC: Key Financials
Figure 20 BioMimetic Therapeutics LLC: Segmental Revenue
Figure 21 BioMimetic Therapeutics LLC: Geographical Revenue
Figure 22 Stryker Corporation: Key Financials
Figure 23 Stryker Corporation: Segmental Revenue
Figure 24 Stryker Corporation: Geographical Revenue
Figure 25 RTI Surgical, Inc: Key Financials
Figure 26 RTI Surgical, Inc: Segmental Revenue
Figure 27 RTI Surgical, Inc: Geographical Revenue
Figure 28 Olympus Biotech Corporation: Key Financials
Figure 29 Olympus Biotech Corporation: Segmental Revenue
Figure 30 Olympus Biotech Corporation: Geographical Revenue
Figure 31 NuVasive, Inc.: Key Financials
Figure 32 NuVasive, Inc.: Segmental Revenue
Figure 33 NuVasive, Inc.: Geographical Revenue
Figure 34 NovaBone Products LLC: Key Financials
Figure 35 NovaBone Products LLC: Segmental Revenue
Figure 36 NovaBone Products LLC: Geographical Revenue
Figure 37 Smith & Nephew Plc: Key Financials
Figure 38 Smith & Nephew Plc: Segmental Revenue
Figure 39 Smith & Nephew Plc: Geographical Revenue